DCGI recommends Serum Institute’s qHPV vaccine against cervical cancer

New Delhi: The Drugs Controller General of India’s (DCGI) Subject Expert Committee on Wednesday recommended Serum Institute‘s indigenously developed quadrivalent human papillomavirus (qHPV) vaccine for cervical cancer patients.

“An expert panel of India’s central drug authority on Wednesday recommended granting of market authorisation to Serum Institute of India‘s indigenously-developed India’s first quadrivalent human papillomavirus vaccine (qHPV) against cervical cancer,” a source said.

The vaccine has been recommended for cervical cancer patients – those above 9 years to 26 years of age – for both male and female.

According to the source, an application has also been sent to the National Technical Advisory Group on Immunisation (NTAGI) and it may take the final decision on the HPV vaccine in the next meeting scheduled to be held on June 29.

Cervical cancer forms 16.5 per cent of the total cancer cases in Indian women and is the second most common type of cancer amongst women in the country after breast cancer. It is caused by the human papillomavirus (HPV), a virus that is generally transmitted through sexual contact.

  • Related Posts

    • Pharma
    • July 3, 2025
    • 98 views
    Cipla in talks to add new customers for its China factory, executive says

    SHANGHAI – Indian drugmaker Cipla (CIPL.NS), opens new tab is looking to add at least two new overseas markets for its products manufactured in China, as the firm seeks to…

    • Pharma
    • July 3, 2025
    • 90 views
    No link between COVID-19 vaccines & sudden deaths: ICMR-AIIMS Study

    ​Union Minister of Health and Family Welfare said that extensive studies by the Indian Council of Medical Research (ICMR) and All India Institute of Medical Sciences have conclusively established no…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    Cipla in talks to add new customers for its China factory, executive says

    Cipla in talks to add new customers for its China factory, executive says

    No link between COVID-19 vaccines & sudden deaths: ICMR-AIIMS Study

    No link between COVID-19 vaccines & sudden deaths: ICMR-AIIMS Study

    Delhi High Court asks DGCI to decide on plea against licensing of weight-loss drugs

    Delhi High Court asks DGCI to decide on plea against licensing of weight-loss drugs

    Microplastics found in brain, ovaries, and placenta: Experts warn of silent threat to vital organs

    Microplastics found in brain, ovaries, and placenta: Experts warn of silent threat to vital organs